Search

Abbott Laboratories

Lezárt

SzektorEgészségügy

103.9 0.47

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

103.41

Maximum

103.95

Fő mutatók

By Trading Economics

Bevétel

-149M

928M

Értékesítés

1.4B

13B

P/E

Szektor átlag

33.786

49.241

Egy részvényre jutó nyereség

1.31

Osztalékhozam

2.36

Profit margin

7.369

Munkavállalók

122,000

EBITDA

548M

2.8B

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+17.76% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

2.36%

2.15%

Következő eredményjelentés

2027. jan. 21.

Következő osztalékfizetési dátum

2026. nov. 16.

Következő korábbi osztalék dátum

2027. jan. 14.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

16B

180B

Előző nyitás

103.43

Előző zárás

103.9

Abbott Laboratories Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. okt. 23. 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, experiencing notable volatility after shifting from slight gains to losses.

2026. okt. 22. 23:51 UTC

Abbott Laboratories is gaining modestly in after-market trading, positioned significantly above its 20-day moving average and nearing the upper end of its one-month trading range.

2026. okt. 21. 23:06 UTC

Abbott Laboratories shares are trading slightly higher in after-market hours, amid broader equity gains following a significant decline in U.S. crude oil inventories.

2026. okt. 20. 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours, continuing a downward trend amid broader weakness in the Health Care Equipment sub-sector.

2026. okt. 19. 23:41 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours after retracing from an early peak above Monday's close.

2026. okt. 17. 00:01 UTC

Abbott Laboratories is trading modestly lower in after-market hours, retracing from a brief uptick earlier.

2026. okt. 16. 23:01 UTC

Abbott Laboratories shares are trading modestly lower in after-market hours, following a brief rise earlier, amid ongoing volatility.

2026. okt. 15. 23:06 UTC

Abbott Laboratories is trading lower in after-market hours, with cumulative returns dipping below Thursday's close after fluctuating during the session.

2026. okt. 14. 23:31 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting strength as they trade above their 20-day moving average and near the upper end of their one-month range.

2026. okt. 13. 20:08 UTC

Abbott Laboratories shares advanced, closing modestly above Monday's close, despite pulling back from an early session high during Tuesday's trading.

2026. okt. 12. 23:06 UTC

Abbott Laboratories is trading higher in after-market hours, continuing a trend of three consecutive daily closes with slight upward movement since Monday's close.

2026. okt. 10. 00:01 UTC

Abbott Laboratories is trading higher in after-market hours, marking the highest cumulative return since Friday's close and showing unusual strength within its one-month range.

2026. okt. 9. 22:01 UTC

Abbott Laboratories shares advanced in after-market trading, reflecting a modest increase since Friday's close while fluctuating around the middle of its one-month range.

2026. okt. 8. 22:45 UTC

Abbott Laboratories shares are trading lower in after-market hours, remaining below their 20-day moving average and near the lower end of their one-month range.

2026. okt. 7. 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

2026. okt. 6. 20:07 UTC

Abbott Laboratories shares fell sharply after an earlier rise, reaching their lowest point of the day and remaining below the 20-day moving average.

2026. okt. 5. 23:05 UTC

Abbott Laboratories is trading slightly higher in after-market hours, while the S&P Global Composite PMI rose to 58.4, indicating strong growth in the U.S. economy.

2026. okt. 2. 20:07 UTC

Social Media
News

Abbott Laboratories upgraded to Buy from Hold by Rothschild & Co Redburn, with a price target increase to $127, as shares trade modestly higher.

2026. okt. 1. 20:07 UTC

Abbott Laboratories shares fell sharply, closing at their lowest point for the session and trading well below the 20-day moving average.

2026. szept. 30. 20:07 UTC

News

Abbott Laboratories launched SimpleScreen CRC, an FDA-approved blood test for colorectal cancer, but shares fell amid broader market trends.

2026. szept. 29. 23:00 UTC

Abbott Laboratories is declining in after-market trading, finishing lower for three consecutive sessions and positioned significantly below its 20-day moving average.

2026. szept. 25. 20:07 UTC

Abbott Laboratories' shares are higher amid a broader market rally, recovering from an earlier pullback but still below its 20-day moving average.

2026. szept. 24. 19:51 UTC

Macro Event

Abbott Laboratories shares fell, diverging from recent gains, amid a report showing a slight improvement in U.S. Jobless Claims' 4-week Average.

2026. szept. 23. 20:01 UTC

News

Abbott Laboratories announced a partnership with Berry Street for personalized nutrition support, but shares fell amid broader market reactions to insider trading activity.

2026. szept. 22. 23:41 UTC

Abbott Laboratories is seeing a modest increase in after-market trading, following three consecutive higher daily closes despite being below its 20-day moving average.

2026. szept. 21. 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

2026. szept. 16. 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

2026. szept. 15. 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

2026. szept. 14. 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

2026. szept. 12. 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

Társak összehasonlítása

Árváltozás

Abbott Laboratories Előrejelzés

Célár

By TipRanks

17.76% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 122.118 USD  17.76%

Magas 135 USD

Alacsony 115 USD

19 Wall Street elemző 12 hónapos célárain alapulva a(z)Abbott Laboratories termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

19 ratings

18

Vétel

1

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
help-icon Live chat